Overview

Safety Study of Once a Day ART and Opiate Substitute.

Status:
Completed
Trial end date:
2006-06-01
Target enrollment:
Participant gender:
Summary
This study looks at HIV-infected subjects who are on methadone treatment and medicines for HIV.
Phase:
Phase 4
Details
Lead Sponsor:
Gilead Sciences
Treatments:
Tenofovir